Markets:

Overview

News

Currencies

International

Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

6.440 +0.320 (+5.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

February 23, 2022

On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

World Markets News For Thursday ↗

February 17, 2022

Ericsson stock lost another 5.27% today in US markets.

Via Talk Markets

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Give peace a chance ↗

February 15, 2022

Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today.

Via Talk Markets

Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant ↗

February 10, 2022

In January, amid the omicron surge, WHO's expert panel recommended GlaxoSmithKline Plc (NYSE

Via Benzinga

Inflation inflating ↗

February 10, 2022

The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.

Via Talk Markets

Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus ↗

February 08, 2022

Immunome Inc (NASDAQ: IMNM) shares rose before falling after reporting results from testing its experimental three-antibody cocktail

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Panic reversal ↗

January 26, 2022

Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise.

Via Talk Markets

WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge ↗

January 14, 2022

An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc...

Via Benzinga

GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19 ↗

January 13, 2022

GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc (NASDAQ: VIR) have applied to the FDA to include intramuscular (IM) administration to sotrovimab...

Via Benzinga

Vir Biotechnology Expands Partnership With Bill & Melinda Gates Foundation, Launches New Antibody Research Initiative Aimed At A Functional Cure For HIV And Prevention Of Malaria; Foundation Has Committed $40M Equity Investment And $10M Grant ↗

January 13, 2022

Vir Biotechnology, Inc. (NASDAQ: VIR) today announced an expansion of its partnership with the Bill & Melinda Gates Foundation to include the advancement of innovative...

Via Benzinga

Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies ↗

January 13, 2022

Adagio Therapeutics Inc (NASDAQ: ADGI) shares gain during the premarket session after recent findings showing that ADG20 has neutralization activity against the omicron...

Via Benzinga

20 Stocks Moving in Thursday's Pre-Market Session ↗

January 13, 2022

Gainers BTCS Inc. (NASDAQ: BTCS) rose 41% to $9.45 in pre-market trading after jumping 19% on Wednesday. Adagio Therapeutics, Inc. (NASDAQ: ADGI) rose 22.8% to $7.16 in pre-...

Via Benzinga

50 Biggest Movers From Yesterday ↗

January 13, 2022

Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for...

Via Benzinga

US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy ↗

January 11, 2022

The U.S. has agreed to buy 600,000 more doses of GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 antibody...

Via Benzinga

Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant ↗

December 29, 2021

Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The...

Via Benzinga

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key...

Via Talk Markets

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...

Via Benzinga

Xmas Eve ↗

December 24, 2021

About 2000 flights which airlines were proposing to run today have been canceled because of virus not only amongst passengers but also among the crew.

Via Talk Markets

55 Biggest Movers From Yesterday ↗

December 22, 2021

Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) gained 44.8...

Via Benzinga

Plague Year Reversal ↗

December 21, 2021

Just in time for Christmas, the market decided to go up today pretty much across the board.

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 21, 2021

Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 28.4...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

December 21, 2021

Gainers Reliance Global Group, Inc. (NASDAQ: RELI) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) climbed 71.4% to $13.06 after gaining...

Via Benzinga

Alibaba Downgrade, Micron Upgrades Among Today's Top Calls On Wall Street ↗

December 21, 2021

Atlantic Equities analyst James Cordwell downgraded Alibaba to Neutral from Overweight with a price target of $140, down from $185.

Via Talk Markets

Glaxo-Vir Biotech's Antibody Approved In Europe For Early Treatment Of COVID-19 ↗

December 17, 2021

The European Commission (EC) has granted marketing authorization to GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR)...

Via Benzinga

Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain ↗

December 16, 2021

Two tests from independent labs suggest Adagio's antibody could still target omicron.

Via Investor's Business Daily

46 Biggest Movers From Yesterday ↗

December 16, 2021

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 15, 2021

Gainers Biofrontera (NASDAQ:

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

All News about Vir Biotechnology, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today